Generi
c methodology for the automated preparation andanalysis of drug levels in plasma samples within a drugdis
covery environment was a
chieved through the redesignof a protein pre
cipitation assay to a mi
crotiter (96-well)plate format and the appli
cation of roboti
c liquid handlingfor performan
ce of all transfer and pipetting steps. Validation studies revealed that the appli
cation of roboti
cs tosample preparation, in general, maintained the analyti
cala
ccura
cy and pre
cision
compared with preparing samplesmanually. The use of rapid gradient LC-MS/MS foranalysis
coupled with flow diversion of the solvent frontallowed the introdu
ction of protein-pre
cipitated samplesinto the mass spe
ctrometer without the ne
cessity forsour
ce
cleaning. The problem inherent in automati
callypipetting plasma,
caused by fibrinogen
clots, was over
come by storing samples at -80
C and thus pre
cluding
clot formation. The resulting methodology allowed samplepreparation for a 96-well plate designed to a
ccommodate54 unknowns, dupli
cate 12-point
calibration
curves, and6 sets of quality
controls at three levels in approximately2 h. This approa
ch allowed an in
crease in throughput ofsample preparation and analysis to >400 samples per dayper LC-MS/MS instrument with minimal manual intervention. Overall, substantial time savings were realized,demonstrating that automation is an in
creasingly essentialtool in a drug dis
covery bioanalyti
cal environment.